Literature DB >> 15958460

Lung cancer screening: panacea or pipe dream?

A K Ganti1, J L Mulshine.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15958460     DOI: 10.1093/annonc/mdi723

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  The potential for using risk models in future lung cancer screening trials.

Authors:  John K Field; Olaide Y Raji
Journal:  F1000 Med Rep       Date:  2010-05-24

2.  Twenty-gene-based prognostic model predicts lung adenocarcinoma survival.

Authors:  Kai Zhao; Zulei Li; Hui Tian
Journal:  Onco Targets Ther       Date:  2018-06-12       Impact factor: 4.147

3.  A novel CpG-based signature for survival prediction of lung adenocarcinoma patients.

Authors:  Rongjiong Zheng; Haiqi Xu; Wenjie Mao; Zhennan Du; Mingming Wang; Meiling Hu; Xiaolong Gu
Journal:  Exp Ther Med       Date:  2019-11-15       Impact factor: 2.447

4.  Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma.

Authors:  Yun Liu; Fu Liu; Xintong Hu; Jiaxue He; Yanfang Jiang
Journal:  Clin Med Insights Oncol       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.